000 01481 a2200421 4500
005 20250512133300.0
264 0 _c19700906
008 197009s 0 0 eng d
022 _a0365-463X
024 7 _a10.1111/j.0954-6820.1969.tb16721.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVidebaek, A
245 0 0 _aGlucocorticoids in haematology.
_h[electronic resource]
260 _bActa medica Scandinavica. Supplementum
_c1969
300 _a35-41 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdult
650 0 4 _aAgranulocytosis
_xdrug therapy
650 0 4 _aAnemia, Hemolytic, Autoimmune
_xdrug therapy
650 0 4 _aAntibodies
650 0 4 _aBlood Cell Count
650 0 4 _aBlood Cells
_xdrug effects
650 0 4 _aChild
650 0 4 _aGlucocorticoids
_xadverse effects
650 0 4 _aHematologic Diseases
_xdrug therapy
650 0 4 _aHemorrhagic Disorders
_xprevention & control
650 0 4 _aHumans
650 0 4 _aLeukemia
_xdrug therapy
650 0 4 _aLeukocytes
_xdrug effects
650 0 4 _aLeukopenia
_xchemically induced
650 0 4 _aLymphopenia
_xchemically induced
650 0 4 _aPhagocytosis
_xdrug effects
650 0 4 _aPrednisone
_xtherapeutic use
650 0 4 _aThrombocytopenia
_xdrug therapy
650 0 4 _aTime Factors
773 0 _tActa medica Scandinavica. Supplementum
_gvol. 500
_gp. 35-41
856 4 0 _uhttps://doi.org/10.1111/j.0954-6820.1969.tb16721.x
_zAvailable from publisher's website
999 _c4916880
_d4916880